Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Axitinib in Malignant Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | May 1, 2009 |
| Phase: | Phase I|Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01211275 |
| Study Type: | Interventional |
| Intervention: | Biological: axitinib|Drug: chemotherapy |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | The Netherlands Cancer Institute|Pfizer |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other|Industry |
| First Received: | September 27, 2010 |
| End Date: | September 1, 2010 |
| Last Updated: | September 28, 2010 |
| Last Verified: | September 1, 2010 |